Loading company…
Won a federal SBIR/STTR research award from HHS and other federal agencies.
VIVA Viral Vaccines, Inc has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $299,968 in 2025. These are non-dilutive federal research grants, not equity financing. The company is based in Ithaca, New York.
1 round · latest STTR Phase I award (HHS), Sep 2025
Sign in to see 1 rounds.
Sign inNo investors recorded yet for VIVA Viral Vaccines, Inc.
Add an investorVIVA Viral Vaccines, Inc has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for VIVA Viral Vaccines, Inc.
Add diversity data